Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers-Reference-Cited by-同舟云学术

Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers

Published:2010-11 Issue:11 Volume:5 Page:1734-1740
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lee Shin Yup,Kim Min Jung,Jin Guang,Yoo Seung Soo,Park Ji Young,Choi Jin Eun,Jeon Hyo Sung,Cho Sukki,Lee Eung Bae,Cha Seung Ick,Park Tae-In,Kim Chang Ho,Jung Tae Hoon,Park Jae Yong

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference45 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

2. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors;Rowinsky;Annu Rev Med,2004

3. The epidermal growth factor receptor family: biology driving targeted therapeutics;Wieduwilt;Cell Mol Life Sci,2008

4. Mutations and response to epidermal growth factor receptor inhibitors;Laurent-Puig;Clin Cancer Res,2009

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of postoperative recurrence-free survival in non–small cell lung cancer patients based on consensus clustering;Clinical Radiology;2024-10

2. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example;Molecular Biomedicine;2024-04-15

3. A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer;Medicine;2024-02-23

4. Case Report: Response to ALK-TKIs in a metastatic lung cancer patient with morphological heterogeneity and consistent molecular features;Frontiers in Oncology;2023-08-11

5. A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations;Nature Communications;2022-11-14